In turn, GSK3β phosphorylates tau on a set of residues known to be phosphorylated in AD (Lucas et al., 2001; Leroy et al., 2007; Saeki et al., 2011; De Ferrari et al., 2014; Llorens-Martín et al., 2014). Here, MAPT is linked to Alzheimer disease.